SWASTI VINAYAKA | VIMTA LABS | SWASTI VINAYAKA/ VIMTA LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 11.5 | 18.8 | 60.9% | View Chart |
P/BV | x | 1.5 | 3.7 | 41.1% | View Chart |
Dividend Yield | % | 0.0 | 0.5 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SWASTI VINAYAKA Mar-22 |
VIMTA LABS Mar-22 |
SWASTI VINAYAKA/ VIMTA LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 10 | 453 | 2.2% | |
Low | Rs | 3 | 156 | 1.7% | |
Sales per share (Unadj.) | Rs | 2.5 | 125.9 | 2.0% | |
Earnings per share (Unadj.) | Rs | 0.4 | 18.7 | 2.1% | |
Cash flow per share (Unadj.) | Rs | 0.4 | 29.2 | 1.5% | |
Dividends per share (Unadj.) | Rs | 0 | 2.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.7 | 0.0% | |
Book value per share (Unadj.) | Rs | 4.2 | 104.5 | 4.0% | |
Shares outstanding (eoy) | m | 40.00 | 22.11 | 180.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.5 | 2.4 | 103.6% | |
Avg P/E ratio | x | 16.4 | 16.3 | 100.6% | |
P/CF ratio (eoy) | x | 14.7 | 10.4 | 141.0% | |
Price / Book Value ratio | x | 1.5 | 2.9 | 51.0% | |
Dividend payout | % | 0 | 10.7 | 0.0% | |
Avg Mkt Cap | Rs m | 251 | 6,727 | 3.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 24 | 714 | 3.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 100 | 2,783 | 3.6% | |
Other income | Rs m | 3 | 14 | 19.1% | |
Total revenues | Rs m | 103 | 2,797 | 3.7% | |
Gross profit | Rs m | 27 | 791 | 3.5% | |
Depreciation | Rs m | 2 | 233 | 0.8% | |
Interest | Rs m | 8 | 15 | 53.0% | |
Profit before tax | Rs m | 20 | 557 | 3.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 5 | 144 | 3.6% | |
Profit after tax | Rs m | 15 | 413 | 3.7% | |
Gross profit margin | % | 27.3 | 28.4 | 96.2% | |
Effective tax rate | % | 25.0 | 25.8 | 97.1% | |
Net profit margin | % | 15.3 | 14.9 | 103.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 191 | 1,244 | 15.4% | |
Current liabilities | Rs m | 49 | 477 | 10.2% | |
Net working cap to sales | % | 141.8 | 27.5 | 515.1% | |
Current ratio | x | 3.9 | 2.6 | 150.1% | |
Inventory Days | Days | 445 | 15 | 2,888.4% | |
Debtors Days | Days | 19,067,002 | 101 | 18,894,716.2% | |
Net fixed assets | Rs m | 143 | 1,808 | 7.9% | |
Share capital | Rs m | 40 | 44 | 90.5% | |
"Free" reserves | Rs m | 129 | 2,267 | 5.7% | |
Net worth | Rs m | 169 | 2,311 | 7.3% | |
Long term debt | Rs m | 47 | 127 | 37.0% | |
Total assets | Rs m | 334 | 3,051 | 11.0% | |
Interest coverage | x | 3.6 | 38.2 | 9.4% | |
Debt to equity ratio | x | 0.3 | 0.1 | 505.9% | |
Sales to assets ratio | x | 0.3 | 0.9 | 32.9% | |
Return on assets | % | 7.0 | 14.0 | 49.6% | |
Return on equity | % | 9.1 | 17.9 | 50.7% | |
Return on capital | % | 13.1 | 23.5 | 56.0% | |
Exports to sales | % | 1.0 | 24.9 | 3.8% | |
Imports to sales | % | 0 | 8.1 | 0.0% | |
Exports (fob) | Rs m | 1 | 693 | 0.1% | |
Imports (cif) | Rs m | NA | 226 | 0.0% | |
Fx inflow | Rs m | 1 | 693 | 0.1% | |
Fx outflow | Rs m | 0 | 226 | 0.0% | |
Net fx | Rs m | 1 | 467 | 0.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 20 | 591 | 3.3% | |
From Investments | Rs m | -1 | -378 | 0.2% | |
From Financial Activity | Rs m | -19 | -166 | 11.5% | |
Net Cashflow | Rs m | 0 | 46 | -1.0% |
Indian Promoters | % | 51.0 | 37.5 | 136.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 2.4 | - | |
FIIs | % | 0.0 | 0.4 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 49.0 | 62.5 | 78.3% | |
Shareholders | 14,773 | 18,106 | 81.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare SWASTI VINAYAKA With: VA TECH WABAG SIS DELTA CORP SYNGENE INTERNATIONAL
On Tuesday, Indian share markets ended on a firm note as fag-end buying in Reliance Industries and other index heavyweight stocks pushed benchmark indices higher.